...
首页> 外文期刊>Journal of Pharmacy and Bioallied Sciences >Anti-obesity activity of chloroform-methanol extract of Premna integrifolia in mice fed with cafeteria diet
【24h】

Anti-obesity activity of chloroform-methanol extract of Premna integrifolia in mice fed with cafeteria diet

机译:食足草中氯仿-甲醇提取物对食堂饮食小鼠的抗肥胖作用

获取原文
           

摘要

Aim of the study:Aim of the present study was to evaluate the anti-obesity activity of chloroform:methanol extract of P. integrifolia (CMPI) in mice fed with cafeteria diet.Materials and Methods:Female Swiss Albino mice were divided into six groups, which received normal and cafeteria diet, standard drug simvastatin (10 mg/kg) and CMPI (50, 100 and 200 mg/kg) daily for 40 days. Parameters such as body weight, body mass index (BMI), Lee index of obesity (LIO), food consumption, locomotor behavior, serum glucose, triglyceride, total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL), very low density lipoprotein (VLDL), atherogenic index, organ weight and organ fat pad weight were studied for evaluating the anti-obesity activity of P. integrifolia. High performance liquid chromatography (HPLC) fingerprint profile of chloroform-methanol extract was also studied using quercetin as the reference standard.Results:There was a significant increase in body weight, BMI, LIO, food consumption, organ weight (liver and small intestine), organ fat pad weight (mesenteric and peri-renal fat pad) and in the levels of serum glucose, triglyceride, total cholesterol, LDL and VLDL with a significant decrease in locomotor behavior (ambulation, rearing, grooming) and HDL level in cafeteria diet group. Animals treated with CMPI showed dose dependent activity. P. integrifolia (200 mg/kg) supplementation attenuated all the above alterations, which indicates the anti-obesity activity. HPLC fingerprint profile of CMPI showed two peaks in the solvent system of 50 mm potassium diphosphate (pH-3 with ortho phosphoric acid): Methanol (30:70 v/v) at 360 nm.Conclusion:Present findings suggest that, CMPI possessed anti-obesity activity that substantiated its ethno-medicinal use in the treatment of obesity.
机译:研究目的:本研究的目的是评估食堂饮食喂养的小鼠中的氯仿:整形假单胞菌甲醇提取物(CMPI)的抗肥胖活性。材料与方法:将瑞士白化病小鼠分为六组,每天接受正常饮食和自助餐厅饮食,标准药物辛伐他汀(10 mg / kg)和CMPI(50、100和200 mg / kg),连续40天。诸如体重,体重指数(BMI),肥胖李指数(LIO),食物消耗,运动行为,血糖,甘油三酸酯,总胆固醇,高密度脂蛋白(HDL),低密度脂蛋白(LDL)等参数研究了低密度脂蛋白(VLDL),致动脉粥样硬化指数,器官重量和器官脂肪垫重量,以评估整枝青冈的抗肥胖活性。还以槲皮素为参考标准,研究了氯仿-甲醇提取物的高效液相色谱(HPLC)指纹图谱。结果:体重,BMI,LIO,食物消耗,器官重量(肝脏和小肠)显着增加。食堂饮食中的器官脂肪垫重量(肠系膜和肾周围脂肪垫)以及血清葡萄糖,甘油三酸酯,总胆固醇,LDL和VLDL的水平,运动行为(移动,饲养,修饰)和HDL含量显着降低组。用CMPI治疗的动物表现出剂量依赖性活性。整形青霉(200 mg / kg)补充剂减弱了上述所有变化,表明其具有抗肥胖作用。 CMPI的HPLC指纹图谱在50 mm二磷酸钾(pH-3和正磷酸)的溶剂系统中显示两个峰:甲醇(30:70 v / v)在360 nm。结论:现有发现表明,CMPI具有抗肥胖活动,证实了其在肥胖症治疗中的民族医学用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号